Reading Time: 3 minutesIntroduction Adult-onset growth hormone deficiency (AGHD) is a condition that can significantly impact the quality of life of affected individuals. In American males, this condition can lead to a variety of psychological challenges, including depression, anxiety, and reduced overall well-being. Humatrope, a recombinant human growth hormone, has been utilized as a therapeutic option for AGHD. This article delves into a 4-year longitudinal study that examines the effects of Humatrope therapy on the psychological well-being of American males with AGHD. Study Design and Methodology The study involved 150 American males diagnosed with AGHD, aged between 25 and 55 years. Participants were … Continue reading
-
Injectable Sermorelin
-
Search -
Archives
- April 2025
- March 2025
- February 2025
- April 2024
- March 2024
- December 2023
- November 2023
- October 2023
- September 2023
- August 2023
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- February 2019
- January 2019
-
HGH Decline Charts
-
Sermorelin Products
-
Sermorelin Health